Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway

Xiahenazi Aiyasiding(Wuhan University), Qi‐Zhu Tang(Wuhan University)
Frontiers in Pharmacology
May 3, 2022
Cited by 27


Related Papers